Adherence monitoring with chronic opioid therapy for persistent pain: a biopsychosocial-spiritual approach to mitigate risk.
Adherence monitoring with chronic opioid therapy for persistent pain: a biopsychosocial-spiritual approach to mitigate risk.
复制标题
DOI：
10.1016/j.pmn.2012.08.008
复制
发表时间：
2014-03
影响因子：
1.7
通讯作者：
Coggins, Candace
中科院分区：
文献类型：
--
作者：
Matteliano, Deborah;St Marie, Barbara J.;Oliver, June;Coggins, Candace
阿片类药物是治疗持续性疼痛的主要药物。虽然这些药物旨在改善舒适度和功能，但在提供护理时必须考虑滥用或成瘾的固有风险。生活在持续疼痛中的经历通常包括抑郁、恐惧、失落和焦虑，导致绝望、无助和精神危机的感觉。总的来说，这些因素对所有患者来说都是风险增加的，特别是那些有药物滥用或成瘾史的患者。这篇伴随文章的重点是持续性疼痛、SUD和慢性阿片类药物治疗的交叉，以及监测阿片类药物对持续性疼痛患者安全使用的依从性的临床意义。本文提出了一种综合评估接受阿片类药物治疗时持续性疼痛患者的方法，通过扩展生物心理社会模型，现在包括与疼痛和SUD相关的精神因素，从而制定了一种生物心理社会精神方法来降低风险。使用作者开发的生物心理社会精神评估模型作为促进敏感和尊重护理的手段，为依从性监测提供了关键原则。
Opioids represent a mainstay in the pharmacological management of persistent pain. While these drugs are intended to support improved comfort and function, the inherent risk of abuse or addiction must be considered in the delivery of care. The experience of living with persistent pain often includes depression, fear, loss, and anxiety, leading to feelings of hopelessness, helplessness, and spiritual crisis. Collectively, these factors represent an increased risk for all patients, particularly those with a past history of substance abuse or addiction. This companion article to the focuses on the intersection of persistent pain, SUD, and chronic opioid therapy and the clinical implications of monitoring adherence with safe use of opioids for those with persistent pain. This paper presents an approach to the comprehensive assessment of persons with persistent pain when receiving opioid therapy by presenting an expansion of the biopsychosocial model to now include spiritual factors associated with pain and SUD, thus formulating a biopsychosocial-spiritual approach to mitigate risk. Key principles are provided for adherence monitoring using the biopsychosocial-spiritual assessment model developed by the authors as a means of promoting sensitive and respectful care.
登录
查看更多内容
DOI：
10.1016/j.jpain.2008.10.008
发表时间：
2009-02
期刊：
The journal of pain
影响因子：
--
作者：
Chou R;Fanciullo GJ;Fine PG;Adler JA;Ballantyne JC;Davies P;Donovan MI;Fishbain DA;Foley KM;Fudin J;Gilson AM;Kelter A;Mauskop A;O'Connor PG;Passik SD;Pasternak GW;Portenoy RK;Rich BA;Roberts RG;Todd KH;Miaskowski C;American Pain Society-American Academy of Pain Medicine Opioids Guidelines Panel
通讯作者：
American Pain Society-American Academy of Pain Medicine Opioids Guidelines Panel
影响因子：
7.4
作者：
Butler, SF;Budman, SH;Jamison, RN
通讯作者：
Jamison, RN
影响因子：
3.1
作者：
Buessing, Arndt;Michalsen, Andreas;Matthiessen, Peter F.
通讯作者：
Matthiessen, Peter F.
影响因子：
4.7
作者：
Adams, LL;Gatchel, R;Noe, C
通讯作者：
Noe, C
影响因子：
2.9
作者：
Chabal, C;Erjavec, MK;Chaney, E
通讯作者：
Chaney, E